[HTML][HTML] Sexual dimorphism in chronic hepatitis B virus (HBV) infection: evidence to inform elimination efforts

R Brown, P Goulder, PC Matthews - Wellcome Open Research, 2022 - ncbi.nlm.nih.gov
Sexual dimorphism in infectious diseases refers to the different infection susceptibilities and
outcomes between males and females, and has been described for many pathogens …

Hepatitis B infection among pregnant women in China: a systematic review and meta-analysis

D Liu, Y Liu, J Ni, H Li, L Zeng, C Zhang… - Frontiers in public …, 2022 - frontiersin.org
Background A study of the current situation and characteristics of hepatitis B virus (HBV)
infection among Chinese pregnant women is meaningful to provide baseline information for …

[HTML][HTML] Antiviral Therapy Favors a Lower Risk of Liver Cirrhosis in HBeAg-negative Chronic Hepatitis B with Normal Alanine Transaminase and HBV DNA Positivity

J Zhou, FD Wang, LQ Li, YJ Li, SY Wang… - Journal of Clinical and …, 2023 - ncbi.nlm.nih.gov
Methods HBeAg-negative patients with normal ALT and positive HBV DNA (≥ 20 IU/mL)
were retrospectively enrolled. The endpoints included virological response (HBV DNA< 100 …

Significant metabolic alterations in patients with hepatitis B virus replication observed via serum untargeted metabolomics shed new light on hepatitis B virus infection

L Yu, Z Zeng, H Tan, Q Feng, Q Zhou, J Hu… - Journal of Drug …, 2022 - Taylor & Francis
Until now, the metabolic effects of hepatitis B virus (HBV) replication on the progression of
hepatic diseases (hepatitis, cirrhosis, and liver cancer) and liver functions have remained …

Expanding antiviral therapy indications for HBeAg-negative chronic hepatitis B patients with normal ALT and positive HBV DNA

J Zhou, F Wang, L Li, E Chen - Precision Clinical Medicine, 2022 - academic.oup.com
With the improved efficacy and accessibility of antiviral agents as well as the concerns about
disease progression, there is a hot discussion on whether HBeAg-negative chronic hepatitis …

《 慢性乙型肝炎防治指南(2022 年版)》 修订过程中关于慢性HBV 感染自然史的讨论.

庄辉 - … of Clinical Hepatology/Linchuang Gandanbing Zazhi, 2023 - search.ebscohost.com
庄辉 Page 1 !()-.! DOI:10. 3969 / j. issn. 1001 r 5256. 2023. 06. 006 《慢性乙型肝炎防治指南(2022
年版) 》修订过程中关于慢性 HBV 感染自然史的讨论 庄辉 北京大学医学部病原生物学系和感染病 …

Chronic Hepatitis B: Treat all Who Are Viremic?

F Su, IM Jacobson - Clinics in Liver Disease, 2023 - liver.theclinics.com
The goals of antiviral therapy in patients with chronic hepatitis B (CHB) are to prevent
disease progression and reduce the risk of hepatocellular carcinoma (HCC). 1–3 Treatment …

IFIT3 Is Increased in Serum from Patients with Chronic Hepatitis B Virus (HBV) Infection and Promotes the Anti-HBV Effect of Interferon Alpha via JAK-STAT2 In Vitro

S Xu, J Huang, Z Xun, S Li, Y Fu, N Lin… - Microbiology …, 2022 - Am Soc Microbiol
Increasing evidence indicates that interferon alpha (IFN-α) therapy is an effective treatment
option for a subgroup of patients with chronic hepatitis B virus (HBV) infection. It has been …

Favourable Prognosis of Patients With Untreated HBeAg‐Negative Chronic Hepatitis B Virus Infection With HBsAg< 100 IU/mL

J Wang, Z Zhang, S Yin, S Zhang, L Zhu… - Alimentary …, 2025 - Wiley Online Library
Background Serum hepatitis B surface antigen (HBsAg)< 100 IU/mL has been recently
proposed as one of the key criteria of 'partial cure'in patients with chronic hepatitis B virus …

Antiviral therapy for chronic HBV infection with persistently normal alanine aminotransferase: Controversy and consensus

J Zhou, FD Wang, ML Wang, YC Tao, DB Wu… - Frontiers in …, 2021 - frontiersin.org
ALT is one of the most sensitive biochemical indexes to reflect liver injury. It is generally
believed that hepatitis B virus (HBV) infected patients with normal ALT levels are in either …